21 related articles for article (PubMed ID: 29653432)
1. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
2. N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase.
Heise N; Friedrich S; Temml V; Schuster D; Siewert B; Csuk R
Eur J Med Chem; 2022 Jan; 227():113947. PubMed ID: 34731766
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking simulation studies on potent butyrylcholinesterase inhibitors obtained from microbial transformation of dihydrotestosterone.
Zafar S; Choudhary MI; Dalvandi K; Mahmood U; Ul-Haq Z
Chem Cent J; 2013 Oct; 7(1):164. PubMed ID: 24103815
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization and Biological Evaluation of Benzothiazole-Isoquinoline Derivative.
Liu W; Zhao D; He Z; Hu Y; Zhu Y; Zhang L; Jin L; Guan L; Wang S
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558194
[TBL] [Abstract][Full Text] [Related]
5. Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of
Jusril NA; Muhamad Juhari ANN; Abu Bakar SI; Md Saad WM; Adenan MI
Molecules; 2020 Jul; 25(15):. PubMed ID: 32721993
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
7. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
8. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
[TBL] [Abstract][Full Text] [Related]
9. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors.
Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796
[TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.
Begum S; Nizami SS; Mahmood U; Masood S; Iftikhar S; Saied S
Comput Biol Chem; 2018 Jun; 74():212-217. PubMed ID: 29653432
[TBL] [Abstract][Full Text] [Related]
12. Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases.
Scotti L; Scotti MT
Curr Top Med Chem; 2015; 15(21):2239-52. PubMed ID: 26059353
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
